Just A Few Early Guesses — At Merck’s Q2 2013 Results

Updated: I’ll concur with the average Street estimates and expect EPS of $0.83, on revenue of $11.2 billion, come Tuesday morning.

I’ll refine this a bit (see preliminary graphic at right) — with some actual EPS and global sales revenue guesses at some point —  but since Pfizer’s Q2 2013 results press release is also on Tuesday morning, I can’t really cheat by looking at what Pfizer turns in.

Yes, Merck will be reporting at nearly the same time.

In any event, see the “Kentucky windage” I’ve thus far gleaned — solely from reading J&J’s Q2 release a few weeks back.

Most Wall Street analysts expect an “in-line” quarter, when Merck reports on Tuesday morning. Do tune in.


Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s